New research suggests statins may protect adults with type 2 diabetes regardless of how low their predicted heart risk appears. In a large UK study, statin use was linked to fewer deaths and major cardiac events across all risk levels. Even those labeled “low risk” benefited, challenging long-held assumptions about who should receive preventive therapy. Side effects were rare and generally mild.
Categories
Recent Posts
- My FSHD journey revealed new strength I never knew I had
- In Case You Missed It…
- Scientists uncover why 1 steroid but not another slows growth in Duchenne boys
- FDA Grants Priority Review to Potential Duchenne Treatment Del-Zota
- Novartis Shares Del-Zota Regulatory Update: FDA Accepts BLA for Priority Review
Archive
- September 2026
- August 2026
- July 2026
- June 2026
- May 2026
- April 2026
- March 2026
- February 2026
- January 2026
- December 2025
- November 2025
- October 2025
- September 2025
- August 2025
- July 2025
- June 2025
- May 2025
- April 2025
- March 2025
- February 2025
- January 2025
- December 2024
- November 2024
- October 2024
- September 2024
- August 2024
- July 2024
- June 2024
- May 2024
- April 2024
- March 2024
- February 2024
- January 2024
